Luye Pharma Group Ltd Financials

Market Capitalization HK$12.30 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	23.00
Forward PE	10.22
Price to Sales TTM	HK$1.79
Price to Book MRQ	HK$0.64
Enterprise to Revenue	2.46
Enterprise to EBITDA	7.77

Financial Reports as of Jun. 30, 2012

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2012-06-30
Profit Margin	6.44%
Operating Margin	19.19%
Return on Assets TTM	2.41%
Return on Equity TTM	3.68%

Income Statement

Revenue TTM	HK$6,869,698,574
Revenue per Share TTM	HK$1.64
Quarterly Revenue Growth	3.50%
Gross Profit TTM	HK$4,592,392,266
EBITDA	HK$336,593,000
Net Income to Common TTM	HK$442,095,408
Diluted EPS TTM	HK$0.12
Quarterly Earnings Growth YoY	-19.30%

Balance Sheet

Total Cash MRQ	HK$9,837,981,090
Total Cash per Share MRQ	HK$2.35
Total Debt MRQ	HK$
Total Debt to Equity MRQ	71.76
Current Ratio MRQ	1.31
Book Value per Share MRQ	HK$4.34

Cash Flow

Operating Cash Flow TTM	HK$2,613,479,089
Levered Free Cash Flow TTM	HK$-1,336,081,343

2186 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	3,761,670,643
Float Shares	2,068,053,669
Avg 10 Volume	9,882,140
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	31.20%
% Held by Institutions	26.65%

Stock Price Summary

Beta	1.02
Fifty Two Week Low	HK$1.67
Fifty Two Week High	HK$4.49
Fifty Two Week Change	23.83%
Day 50 MA	HK$3.03
Day 200 MA	HK$3.07

Dividends and Splits

Forward Annual Dividend Rate	HK$0.12
Forward Annual Dividend Yield	4.33%
Trailing Annual Dividend Rate	HK$0.13
Trailing Annual Dividend Yield	4.58%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2020-06-29
Last Split Factor
Last Split Date